viprostol

Known as: 15-(deoxy)-16-hydroxy-16-vinylprostaglandin E2 methyl ester, 15-deoxy-16-hydroxy-16-vinyl-PGE2 methyl ester, DHV-PGE2Me 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Dit boekje wil bouwstenen aanreiken voor het proces dat herstel van de Vecht naar een halfnatuurlijke laaglandrivier beoogt. In… (More)
Is this relevant?
1992
1992
The purpose of this study was to gain insight into the mechanism(s) responsible for the exaggerated angiotensin II (ANG II… (More)
Is this relevant?
1992
1992
The objective of this study was to investigate the ability of the vasodilator prostaglandins E2 (PGE2) and I2 (PGI2) to interact… (More)
Is this relevant?
1990
1990
Fifty-seven men were randomly assigned for treatment of androgenetic alopecia with viprostol, vehicle, or placebo twice daily for… (More)
Is this relevant?
Review
1989
Review
1989
Our investigations were aimed toward a better understanding of the fate of viprostol in the skin following topical administration… (More)
Is this relevant?
1989
1989
The effects of three formulations on the transdermal absorption and antihypertensive activity of 14C-viprostol were investigated… (More)
Is this relevant?
1987
1987
Viprostol, a novel prostaglandin E2 congener, was assessed for in vitro antilipolytic activity in the spontaneously obese rat. In… (More)
Is this relevant?
1987
1987
1. Topical application of 14C-viprostol, a synthetic prostaglandin E2 analogue, to laboratory animals resulted in a significant… (More)
Is this relevant?
1986
1986
The relative inhibitory potency of prostaglandin A (PGA) and prostaglandin J2 (PGJ2) analogues compared to prostaglandin A1 (PGA1… (More)
  • table I
  • table 3
  • figure 1
  • figure 2
Is this relevant?
1982
1982
Topically applied 16-vinylprostaglandins demonstrate the property of rapid transit through the skin and a profound effect on the… (More)
Is this relevant?